# Johnson & Johnson (JNJ) — Q1-2018 Earnings Results

**Report date:** 2018-04-17 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2018

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.06 | N/A | +1.51% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's ability to navigate market challenges. They noted positive trends in product demand.

**Key quotes:**

> Management highlighted strong performance in key segments.

> They emphasized ongoing commitment to innovation and market expansion.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

This earnings report indicates that Johnson & Johnson performed better than expected on EPS, which reflects positively on their profitability. However, the lack of revenue data and guidance may leave investors cautious. The stock reaction remains unclear due to missing data.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2018_